2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
复制标题
DOI：
10.1016/j.jacc.2011.06.011
复制
发表时间：
2011-12-13
影响因子：
24
通讯作者：
Yancy, Clyde W.
中科院分区：
文献类型：
--
作者：
Gersh, Bernard J.;Maron, Barry J.;Yancy, Clyde W.
1.1.方法论和证据审查本文件中列出的建议尽可能以证据为基础。对证据进行了广泛的审查，直至2011年1月。搜索仅限于在人类受试者中进行的研究、综述和其他证据，并以英语发表。关键词包括但不限于肥厚型心肌病(HCM)、外科肌切开术、消融、运动、心脏性猝死(SCD)、运动员、双腔起搏、左心室流出道(LVOT)阻塞、酒精间隔消融、汽车驾驶和植入型心律转复除颤器(ICD)、导管消融、除颤器、遗传学、基因、基因、医疗管理、磁共振成像、起搏、永久起搏、表型、妊娠、风险分层、运动员猝死、外科间隔
1.1. Methodology and Evidence Review The recommendations listed in this document are, whenever possible, evidence based. An extensive evidence review was conducted through January 2011. Searches were limited to studies, reviews, and other evidence conducted in human subjects and published in English. Key search words included, but were not limited to, hypertrophic cardiomyopathy (HCM), surgical myectomy, ablation, exercise, sudden cardiac death (SCD), athletes, dual-chamber pacing, left ventricular outflow tract (LVOT) obstruction, alcohol septal ablation, automobile driving and implantable cardioverterdefibrillators (ICDs), catheter ablation, defibrillators, genetics, genotype, medical management, magnetic resonance imaging, pacing, permanent pacing, phenotype, pregnancy, risk stratification, sudden death in athletes, surgical septal